| View |
|
DR-XY22898
|
Peritoneal Dialysis Solution with 2.5% Dextrose
|
Dianeal PD-2
|
[see reverse for formulation]
|
Dialysis Solution
|
Dialysis Solution
|
BAXTER HEALTHCARE PHILIPPINES, INC.
|
Philippines
|
Automatic Renewal
|
30 January 2022
|
15 February 2027
|
| View |
|
DR-XY22911
|
Cefalexin (As Monohydrate)
|
Oneflex
|
250 mg / 5 mL
|
Powder for Suspension
|
-
|
Hizon Laboratories, Inc.
|
Philippines
|
-
|
25 May 2021
|
14 April 2026
|
| View |
|
DR-XY22926
|
Formoterol Fumarate
|
Foradil
|
12 mcg
|
Dry Powder For Inhalation
|
-
|
Novartis Pharma Stein AG, Pharmaceutical Operations Schweiz
|
Switzerland
|
-
|
06 April 2020
|
18 March 2025
|
| View |
|
DR-XY22960
|
Magnesium Sulfate
|
None
|
250mg/ mL
|
Solution for Injection (IM/IV)
|
Anticonvulsant
|
e.L. Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
23 December 2021
|
03 June 2027
|
| View |
|
DR-XY22962
|
Multivitamins
|
Heltine
|
Retinol Acetate (Vit. A) Cholecalciferol (Vit. D3) Thiamine Mononitrate (Vit. B1) Riboflavin (Vit, B2) Pyridoxine Hydrochloride (Vit. B6) Cyanocobalamin (Vit. B12)
10,000 IU Ascorbic Acid (Vit. C)
100 mg 400 IU Niacinamide
20 mg 10 mg Calcium Pantothenate 10 mg Ferrous Şulfate
200 mg 5 mg (Equivalent to 60 mg elemental iron)
5 mg
5 mg
|
Capsule
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
06 October 2020
|
25 April 2025
|
| View |
|
DR-XY22981
|
Acetylcysteine
|
Fluimucil
|
100 mg/ 5 mL
|
Syrup
|
Mucolytic
|
Zambon S.p.A.
|
Italy
|
Automatic Renewal
|
11 February 2023
|
08 May 2028
|
| View |
|
DR-XY22982
|
Acetylcysteine
|
Fluimucil
|
600 mg
|
Effervescent Tablet
|
Mucolytic
|
Zambon Switzerland Ltd.
|
Switzerland
|
Automatic Renewal
|
12 October 2022
|
28 January 2028
|
| View |
|
DR-XY2299
|
Desogestrel/Ethinylestradiol
|
Marvelon 28
|
150mcg / 30mcg
|
Tablet
|
-
|
N.V. Organon
|
Netherlands
|
Automatic Renewal
|
14 September 2022
|
16 January 2027
|
| View |
|
DR-XY23015-B
|
Methylergometrine Maleate
|
Cethergo
|
200 mcg/mL
|
Solution For Injection (IM/IV)
|
Oxytocic (Uterine Stimulant)
|
T.P. Drug Laboratories (1969) Co., Ltd.
|
Thailand
|
Automatic Renewal
|
10 April 2023
|
10 July 2028
|
| View |
|
DR-XY23043
|
Acetylcysteine
|
Fluimucil
|
100 mg
|
Granules For Solution
|
Mucolytic
|
Zambon Switzerland Ltd.
|
Switzerland
|
-
|
23 May 2022
|
25 November 2027
|
| View |
DR-XY23051_PI_01.pdf
|
DR-XY23051
|
Verapamil Hydrochloride
|
Isoptin
|
40mg
|
Film Coated Tablet
|
Calcium Channel Blocker
|
AbbVie Deutschland GmbH & Co. KG
|
Germany
|
Renewal
|
27 April 2023
|
14 June 2028
|
| View |
DR-XY23052_PI_01.pdf
|
DR-XY23052
|
Verapamil Hydrochloride
|
Isoptin
|
80mg
|
Film Coated Tablet
|
Calcium Channel Blocker
|
AbbVie Deutschland GmbH & Co. KG
|
Germany
|
Renewal
|
10 May 2023
|
14 June 2028
|
| View |
|
DR-XY23055
|
Paracetamol
|
Anaseran
|
250 mg/5 mL
|
Syrup
|
Non-opioid analgesic / Antipyretic
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
09 June 2022
|
07 July 2027
|
| View |
|
DR-XY23069
|
Miconazole Nitrate
|
Defungin
|
2%
|
Cream
|
ANTIFUNGAL
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
28 April 2022
|
04 July 2027
|
| View |
|
DR-XY23079
|
Felodipine + Metoprolol succinate
|
Logimax
|
5 mg / 47.5 mg (equivalent to 50 mg Metoprolol tartrate)
|
Extended-Release Tablet
|
-
|
AstraZeneca AB
|
Sweden
|
-
|
02 March 2022
|
04 May 2026
|
| View |
|
DR-XY23097-B
|
Vitamin B1 + B6 + B12
|
Neurobexol
|
100 mg/5 mg/50 mcg
|
Capsule
|
Vitamins
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
18 August 2022
|
11 September 2027
|
| View |
|
DR-XY23111
|
Bambuterol Hydrochloride
|
Bambec®
|
10 mg
|
Tablet
|
Selective Beta-2 Adrenoreceptor Agonist
|
AstraZeneca Pharmaceutical Co. Ltd.
|
China
|
Automatic Renewal
|
08 April 2022
|
29 August 2027
|
| View |
|
DR-XY23118
|
Phenylpropanolamine Hydrochloride + Chlorphenamine Maleate
|
Colvan
|
12.5 mg/ 500mcg per 5mL
|
Syrup
|
Nasal Decongestant/Antihistamine
|
Drugmaker's Laboratories Inc.
|
Philippines
|
Automatic Renewal
|
31 January 2023
|
21 February 2028
|
| View |
DR-XY23120_PI_01.pdf
|
DR-XY23120
|
Dobutamine (As Hydrochloride)
|
None
|
12.5mg/ mL
|
Solution For Injection (I.V.)
|
Adrenergic and Dopaminergic agent
|
Hospira, Inc.
|
U.S.A.
|
Renewal
|
27 June 2022
|
21 July 2027
|
| View |
|
DR-XY23125
|
Peritoneal Dialysis Solution with 4.25% Dextrose
|
Dianeal PD-2
|
[see reverse for formulation]
|
Dialysis Solution
|
Dialysis Solution
|
BAXTER HEALTHCARE PHILIPPINES, INC.
|
Philippines
|
Automatic Renewal
|
25 January 2022
|
15 February 2027
|